Skip to main content

The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels

Cunningham, Kevin P., Clapp, Lucie H., Mathie, Alistair, Veale, Emma L. (2021) The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels. Frontiers in Pharmacology, 12 . ISSN 1663-9812. (doi:10.3389/fphar.2021.705421) (KAR id:89481)

PDF Publisher pdf
Language: English


Download (2MB) Preview
[thumbnail of Cunningham et al 2021.pdf]
Preview
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL
https://doi.org/10.3389/fphar.2021.705421
Item Type: Article
DOI/Identification number: 10.3389/fphar.2021.705421
Subjects: Q Science > QP Physiology (Living systems) > QP506 Molecular biology
R Medicine > RM Therapeutics. Pharmacology
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Alistair Mathie
Date Deposited: 27 Jul 2021 19:17 UTC
Last Modified: 28 Jul 2021 09:19 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/89481 (The current URI for this page, for reference purposes)
  • Depositors only (login required):